Study

Pharmacology and safety of tetradecylthioacetic acid (TTA): phase-1 study. – Cost Effective Supplements

Pharmacology and safety of tetradecylthioacetic acid (TTA): phase-1 study.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/18427285


Conclusion of this study

The median peak values were 2.9 mg/L (range, 1.1 to 5.4 mg/L), 11.5 mg/L (range, 4 to 35 mg/L), and 11 mg/L (range, 5 to 25 mg/L), in groups 1, 2, and 3, respectively (P = 0.006). The time to peak levels were 3.5 hours (range, 2.5 to 6.5 hours), 2.5 hours (range, 2.5 to 4.5 hours), and 4.5 hours (range, 2.5 to 12 hours), respectively (P = 0.2). TTA is safe and well tolerated.


Supplements analyzed in this study

TTA

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Heart health


Moderately Positive
TTA


Body systems related to this study


Cardiovascular System
Scroll to top